首页> 美国卫生研究院文献>International Journal of Molecular Sciences >Docetaxel-Loaded Chitosan Microspheres as a Lung Targeted Drug Delivery System: In Vitro and in Vivo Evaluation
【2h】

Docetaxel-Loaded Chitosan Microspheres as a Lung Targeted Drug Delivery System: In Vitro and in Vivo Evaluation

机译:装载多西他赛的壳聚糖微球作为靶向肺的药物递送系统:体外和体内评估

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

The aim of this study was to prepare docetaxel-loaded chitosan microspheres and to evaluate their in vitro and in vivo characteristics. Glutaraldehyde crosslinked microspheres were prepared using a water-in-oil emulsification method, and characterized in terms of the morphological examination, particle size distribution, encapsulation ratio, drug-loading coefficient and in vitro release. Pharmacokinetics and biodistribution studies were used to evaluate that microspheres have more advantage than the conventional formulations. The emulsion crosslinking method was simple to prepare microspheres and easy to scale up. The formed microspheres were spherical in shape, with a smooth surface and the size was uniform (9.6 ± 0.8 μm); the encapsulation efficiency and drug loading of prepared microspheres were 88.1% ± 3.5% and 18.7% ± 1.2%, respectively. In vitro release indicated that the DTX microspheres had a well-sustained release efficacy and in vivo studies showed that the microspheres were found to release the drug to a maximum extent in the target tissue (lung). The prepared microspheres were found to possess suitable physico-chemical properties and the particle size range. The sustained release of DTX from microspheres revealed its applicability as drug delivery system to minimize the exposure of healthy tissues while increasing the accumulation of therapeutic drug in target sites.
机译:这项研究的目的是制备载有紫杉萜的壳聚糖微球并评估其体外和体内特性。戊二醛交联微球采用油包水乳化法制备,并通过形态学检查,粒径分布,包封率,载药率和体外释放进行表征。药代动力学和生物分布研究被用来评估微球比常规制剂更具优势。乳液交联法易于制备微球且易于规模化。形成的微球为球形,表面光滑,尺寸均匀(9.6±0.8μm);制备的微球的包封率和载药量分别为88.1%±3.5%和18.7%±1.2%。体外释放表明DTX微球具有良好的释放功效,体内研究表明,发现微球可在靶组织(肺)中最大程度地释放药物。发现制备的微球具有合适的理化性质和粒径范围。 DTX从微球体的持续释放显示了其作为药物输送系统的适用性,以最大程度地减少健康组织的暴露,同时增加治疗药物在靶部位的积累。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号